BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 17943794)

  • 1. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
    Rambaldi A; Jacobs BP; Gluud C
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003620. PubMed ID: 17943794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
    Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003620. PubMed ID: 15846671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials.
    Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
    Am J Gastroenterol; 2005 Nov; 100(11):2583-91. PubMed ID: 16279916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002148. PubMed ID: 15846629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2001; (3):CD002148. PubMed ID: 11687017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anabolic-androgenic steroids for alcoholic liver disease.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD003045. PubMed ID: 17054157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anabolic-androgenic steroids for alcoholic liver disease.
    Rambaldi A; Iaquinto G; Gluud C
    Cochrane Database Syst Rev; 2003; (1):CD003045. PubMed ID: 12535450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propylthiouracil for alcoholic liver disease.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2002; (2):CD002800. PubMed ID: 12076451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B.
    Liang N; Kong Z; Ma SS; Lu CL; Yang M; Feng LD; Shen C; Diao RH; Cui LJ; Lu XY; Nikolova D; Jakobsen JC; Gluud C; Liu JP
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD013089. PubMed ID: 30941748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propylthiouracil for alcoholic liver disease.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002800. PubMed ID: 16235302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.
    Kong Z; Liang N; Yang GL; Zhang Z; Liu Y; Li J; Liu X; Liang S; Nikolova D; Jakobsen JC; Gluud C; Liu JP
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31697415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation for chronic liver diseases in adults.
    Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Goh ET; Stokes CS; Sidhu SS; Vilstrup H; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012410. PubMed ID: 29762873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propylthiouracil for alcoholic liver disease.
    Fede G; Germani G; Gluud C; Gurusamy KS; Burroughs AK
    Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD002800. PubMed ID: 21678335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
    Mantzoukis K; Rodríguez-Perálvarez M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011645. PubMed ID: 28321877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticosteroids for people with alcoholic hepatitis.
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001511. PubMed ID: 30964545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticosteroids for people with alcoholic hepatitis.
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD001511. PubMed ID: 29096421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for acute hepatitis C infection.
    Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011644. PubMed ID: 30521693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoadamantanes for chronic hepatitis C.
    Lamers MH; Broekman M; Drenth JP; Gluud C
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010125. PubMed ID: 24793264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.